20/20 Biolabs
AIDX----
About
20/20 Biolabs
AIDX.US
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups.
Profile
- Company Name
- 20/20 Biolabs, Inc.
- Market
- NasdaqCM
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- 2020biolabs.com